Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement

Oren K. Fix, Bilal Hameed, Robert J. Fontana, Ryan M. Kwok, Brendan M. McGuire, David C. Mulligan, Daniel S. Pratt, Mark W. Russo, Michael L. Schilsky, Elizabeth C. Verna, Rohit Loomba, David E. Cohen, Jorge A. Bezerra, K. Rajender Reddy, Raymond T. Chung – 16 April 2020

The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction

Junbin Zhou, Jian Chen, Qiang Wei, Kourosh Saeb‐Parsy, Xiao Xu – 15 April 2020 – Liver transplantation (LT) is the only available curative treatment for patients with end‐stage liver disease. Early allograft dysfunction (EAD) is a life‐threatening complication of LT and is thought to be mediated in large part through ischemia/reperfusion injury (IRI). However, the underlying mechanisms linking IRI and EAD after LT are poorly understood.

Subscribe to